Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models

Pathological estimation of tumor necrosis after chemotherapy is essential for patients with osteosarcoma. This study reports the first fully automated tool to assess viable and necrotic tumor in osteosarcoma, employing advances in histopathology digitization and automated learning. We selected 40 digitized whole slide images representing the heterogeneity of osteosarcoma and chemotherapy response. With the goal of labeling the diverse regions of the digitized tissue into viable tumor, necrotic tumor, and non-tumor, we trained 13 machine-learning models and selected the top performing one (a Support Vector Machine) based on reported accuracy. We also developed a deep-learning architecture and trained it on the same data set. We computed the receiver-operator characteristic for discrimination of non-tumor from tumor followed by conditional discrimination of necrotic from viable tumor and found our models performing exceptionally well. We then used the trained models to identify regions of interest on image-tiles generated from test whole slide images. The classification output is visualized as a tumor-prediction map, displaying the extent of viable and necrotic tumor in the slide image. Thus, we lay the foundation for a complete tumor assessment pipeline from original histology images to tumor-prediction map generation. The proposed pipeline can also be adopted for other types of tumor.

[1]  Pau-Choo Chung,et al.  A Fast Algorithm for Multilevel Thresholding , 2001, J. Inf. Sci. Eng..

[2]  Joachim M. Buhmann,et al.  Computational Pathology Analysis of Tissue Microarrays Predicts Survival of Renal Clear Cell Carcinoma Patients , 2008, MICCAI.

[3]  M. Loh,et al.  Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. , 2015, Blood.

[4]  Olaf Hellwich,et al.  Deep convolutional neural networks for automatic classification of gastric carcinoma using whole slide images in digital histopathology , 2017, Comput. Medical Imaging Graph..

[5]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[6]  M. Gebhardt,et al.  Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee , 2016, Pediatric blood & cancer.

[7]  Constantine Katsinis,et al.  Large-scale computations on histology images reveal grade-differentiating parameters for breast cancer , 2006, BMC Medical Imaging.

[8]  J. Eary,et al.  Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomography , 2002, Cancer.

[9]  Jonathan H. Chen,et al.  Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations. , 2017, The New England journal of medicine.

[10]  B. van Ginneken,et al.  Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis , 2016, Scientific Reports.

[11]  Johan A. K. Suykens,et al.  Least Squares Support Vector Machine Classifiers , 1999, Neural Processing Letters.

[12]  J. Ross Quinlan,et al.  Induction of Decision Trees , 1986, Machine Learning.

[13]  A. Huvos,et al.  Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Geoffrey E. Hinton,et al.  ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.

[15]  Ovidiu Daescu,et al.  Histopathological Diagnosis for Viable and Non-viable Tumor Prediction for Osteosarcoma Using Convolutional Neural Network , 2017, ISBRA.

[16]  A. Ruifrok,et al.  Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.

[17]  Daniel L. Rubin,et al.  Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks , 2015, AMIA.

[18]  Yoshua Bengio,et al.  Gradient-based learning applied to document recognition , 1998, Proc. IEEE.

[19]  Bahram Parvin,et al.  When machine vision meets histology: A comparative evaluation of model architecture for classification of histology sections☆ , 2017, Medical Image Anal..

[20]  Ce Zhang,et al.  Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.

[21]  M. Sydes,et al.  International collaboration is feasible in trials for rare conditions: the EURAMOS experience. , 2007, Cancer treatment and research.

[22]  Yoav Freund,et al.  A decision-theoretic generalization of on-line learning and an application to boosting , 1995, EuroCOLT.

[23]  Jian Sun,et al.  Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[24]  José Hernández-Orallo,et al.  Volume under the ROC Surface for Multi-class Problems , 2003, ECML.

[25]  A. Fischer,et al.  Hematoxylin and eosin staining of tissue and cell sections. , 2008, CSH protocols.

[26]  M. Sydes,et al.  Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Thomas G. Dietterich Multiple Classifier Systems , 2000, Lecture Notes in Computer Science.

[28]  Ren-Shyan Liu,et al.  Comparison Between F‐18‐FDG Positron Emission Tomography and Histology for the Assessment of Tumor Necrosis Rates in Primary Osteosarcoma , 2006, Journal of the Chinese Medical Association : JCMA.

[29]  Luca Maria Gambardella,et al.  Mitosis Detection in Breast Cancer Histology Images with Deep Neural Networks , 2013, MICCAI.

[30]  Hai Su,et al.  Region segmentation in histopathological breast cancer images using deep convolutional neural network , 2015, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).

[31]  K. S. Hall,et al.  Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial , 2016, The Lancet. Oncology.

[32]  G. Rosen,et al.  Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. , 1977, Archives of pathology & laboratory medicine.

[33]  Qing Ji,et al.  Dynamic contrast‐enhanced magnetic resonance imaging as a prognostic factor in predicting event‐free and overall survival in pediatric patients with osteosarcoma , 2012, Cancer.

[34]  F. Cabitza,et al.  Unintended Consequences of Machine Learning in Medicine , 2017, JAMA.

[35]  Junzhou Huang,et al.  Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[36]  Mathias Langer,et al.  Osteosarcoma: Preliminary Results of In Vivo Assessment of Tumor Necrosis After Chemotherapy With Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging , 2006, Investigative radiology.

[37]  K. Moon,et al.  Inter and intra-observer reliability in histologic evaluation of necrosis rate induced by neo-adjuvant chemotherapy for osteosarcoma , 2017 .

[38]  P. Leavey Biomarker development in osteosarcoma—Is there no longer any utility to tumor necrosis? , 2016, Pediatric blood & cancer.

[39]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[40]  S. Ferrari,et al.  Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. , 2002, Oncology reports.

[41]  Ovidiu Daescu,et al.  Computer Aided Image Segmentation and Classification for Viable and Non-Viable Tumor Identification in Osteosarcoma , 2017, PSB.

[42]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.